Astrazeneca PLC Press Releases

AZN 
$74.48
*  
0.04
0.05%
Get AZN Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading AZN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
7/28/2014 2:00:00 AM - PR Newswire

Pharma Equities Technical Coverage -- Research on Eli Lilly, AstraZeneca, Allergan, and Provectus Biopharma
6/23/2014 7:20:00 AM - PR Newswire

Data Published In The New England Journal Of Medicine Demonstrate Naloxegol Improved Opioid-Induced Constipation In Chronic Pain Patients
6/19/2014 2:40:00 PM - PR Newswire

Cepheid And Leading Pharmaceutical Companies Partner On A Diagnostic Test To Help Tackle Multidrug-Resistant Bacterial Infections
6/19/2014 7:00:00 AM - PR Newswire

Groundbreaking Collaborative Clinical Trial Launched
6/16/2014 9:00:00 AM - PR Newswire

Brodalumab Treatment Improved Clinical Signs And Symptoms In Phase 2 Psoriatic Arthritis Study Published In The New England Journal Of Medicine
6/11/2014 5:00:00 PM - PR Newswire

Ventana Medical Systems, Inc. and MedImmune collaborate to develop a custom PD-L1 Assay for immunotherapy clinical trials
6/4/2014 10:00:00 AM - PR Newswire

Cigna Customers Prescribed CRESTOR May Lower Their Bad Cholesterol with Reduced Out-of-Pocket Costs
6/2/2014 10:57:00 AM - Business Wire

Pharma Stocks Technical Data -- Research on Provectus Biopharma, AstraZeneca, Eli Lilly, and GlaxoSmithKline
5/27/2014 7:00:00 AM - PR Newswire

Ardelyx Receives $25 Million Milestone From AstraZeneca For Commencement Of Phase 2b Clinical Trial Of Tenapanor
5/15/2014 8:00:00 AM - PR Newswire

SumTotal Webinars Focus on Optimizing Workforce to Meet Compliance Requirements
5/14/2014 10:00:00 AM - Business Wire

Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals for Dyslipidemia-related Diseases
5/14/2014 8:30:00 AM - Business Wire

Amgen And AstraZeneca Announce Positive Results From Phase 3 Study Of Brodalumab (AMG 827) In Patients With Moderate-to-Severe Plaque Psoriasis
5/9/2014 4:01:00 PM - PR Newswire

Fallon Health Achieves Success Using SumTotal Talent Expansion™ for Employee Engagement, Regulatory Compliance
5/6/2014 10:00:00 AM - Business Wire

FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
5/6/2014 2:59:00 AM - PR Newswire

AstraZeneca’s MedImmune Specialty Care to Present Eleven Abstracts on Influenza, RSV at Upcoming Annual Pediatric Academic Societies Meeting
5/3/2014 12:00:00 PM - Business Wire

Technical Recap on Pharma Equities -- Research on Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline
5/1/2014 9:16:00 AM - PR Newswire